Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Polar Capital Global Healthcare Trust plc (PGHZ) ZDP

Sell:108.00p Buy:109.00p 0 Change: No change
Market closed Prices as at close on 13 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:108.00p
Buy:109.00p
Change: No change
Market closed Prices as at close on 13 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:108.00p
Buy:109.00p
Change: No change
Market closed Prices as at close on 13 December 2019 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Open:
108.50p
Trade high:
n/a
Year high:
108.50p
Estimated NAV:
107.60
Previous close:
108.50p
Trade low:
n/a
Year low:
104.00p
Premium/Discount:
0.84%
Previous:
0.00p (0.00%)
Previous:
0.00p
Volume:
n/a
Dividend yield:
n/a
Currency:
GBX
Data delayed by at least 15 minutes.

Price

  • Net Asset Value (NAV)
PCGH ZDP performance chart

Premium/Discount

PCGH ZDP performance chart
Full interactive share price and premium / discount charts

Performance

Not available for this stock.

Trust Basics

Benchmark: MSCI ACWI/Health Care GR USD
Annual management charge: n/a
Performance fee: No
Ongoing charge: 1.15%
Dividend yield: n/a
Dividend frequency: None
Total assets: £329m
Gross gearing: 100%
Market capitalisation:Market cap.: £35m
Shares in issue: 121.27 million
Legal structure Closed Ended Investment Company
Domicile: United Kingdom
ISIN GB00BDHXP963

Dividend information for this stock is not available.

Dividend information for this stock is not available.

Ready to invest?

To buy shares in , you'll need to have an account. Try our handy filter to explore the different options.

Compare accounts

Ready to take your first step?

To invest in , you'll need to open an account.
Try our handy filter to find which one suits you best.

Compare accounts

Important Documents



Objective

The investment objective is to generate capital growth by investing in a global portfolio of healthcare stocks across all four healthcare sub-sectors, being pharmaceuticals, biotechnology, medical technology and healthcare services.

NET ASSET VALUE (NAV)

Estimated NAV: 107.60
Latest actual NAV: 107.62
Latest actual NAV date: 12 December 2019
Premium/Discount: 0.84%
12m average Premium/Discount: 1.25%
NAV frequency: Daily
Time / date Time Buy / sell Type Volume Price Value
09:49 - 10/12 09:49
10/12
Sell 15000 108.11p £16,216.50
11:20 - 09/12 11:20
09/12
Sell 1000 108.12p £1,081.20
×

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.

Security Weight
Merck & Co Inc 6.32%
Sanofi Ordinary Euro 2 5.16%
Novo-Nordisk A/S DKK0.2 B 4.77%
Abbott Laboratories 3.77%
Eli Lilly and Co 3.68%
Koninklijke Philips NV Euro.20 3.65%
Danaher Corp 3.54%
Cigna Corp 3.33%
Grifols SA ADR 3.33%
Bio-Rad Laboratories Inc 3.11%
Sector Weight
Healthcare 107.12%
Country Weight
United States 76.62%
Denmark 8.54%
France 5.80%
United Kingdom 3.71%
Netherlands 3.65%
Spain 3.33%
Switzerland 2.54%
Japan 1.49%
Italy 1.06%
Canada 0.39%

Key Dates

Launch date: 15 June 2010
Financial year end: September
Next AGM: February 2020
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Prices provided by NBTrader. Charts provided by Factset. Dividend data provided by Digital Look. Recent trade data provided by MoneyAM. Trust basics, holding data, key dates, objective and NAV provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.